Skip to content

Amyloidosis Switzerland

Together strong against amyloidosis. We support patients and families with information, counseling, and promote research for better treatment options.

Symbolic image: Medical equipment and devices for the diagnosis and treatment of amyloidosis

What is Amyloidosis?

Amyloidosis is a rare disease in which misfolded proteins (amyloid) accumulate in organs and tissues. These deposits can impair the normal function of various organs. Early diagnosis and treatment are crucial for disease progression.

Rare Disease

Amyloidosis affects only a few people and is often diagnosed late.

Multiple Types

There are different forms such as AL, AA, ATTR amyloidosis with different causes.

Early Detection Important

The earlier amyloidosis is detected, the better the treatment options.

Affects Multiple Organs

Heart, kidneys, nerves and other organs can be affected.

Latest

The association «Leben mit Amyloidose – Amyloidosis Austria» invites patients and their relatives to the information event «ATTR amyloidosis». The event is also live streamed – online participation is possible.

  • Basics of ATTR amyloidosis
  • Current therapies and new developments
  • Mental strength in coping with the disease
  • ATTR beyond the heart, e.g. orthopaedics and gastroenterology
  • Participation on site in Vienna or online via livestream

Registration

Thursday, October 29, 2026, 5:00 PM | Hotel Zeitgeist Vienna, Sonnwendgasse 15, 1100 Vienna. Register at info@amyloidosis-austria.at with your name, number of participants and whether you will attend on site or online.

We warmly invite you to the «Amyloidosis» information event, taking place on Saturday, November 14, 2026, from 9:30 AM to 12:00 PM at Lucerne Cantonal Hospital. From 8:45 AM we welcome you with coffee and croissants.

This event is fully booked. A waiting list is being kept.

  • Talks by leading specialists on cardiac amyloidosis, current and future therapies, and cardiac imaging
  • Exercise with amyloidosis and being well supported through therapy
  • Followed by light refreshments and a personal exchange with the speakers at Restaurant Feingut
  • Free of charge and wheelchair accessible – one accompanying person per patient is welcome

Registration required – deadline October 30, 2026

Saturday, November 14, 2026, 9:30 AM – 12:00 PM | Lucerne Cantonal Hospital, Building 31, main entrance, large auditorium. Please register online via the link below.

Next event

Webinar “Living with amyloidosis – what does me good?” – series 2

14 October 2026 – 8 January 2027

Fridays, 4:00 PM – 6:00 PM

Online

To the agenda

What we do

Support

We provide support in medical and professional areas

Learn more about our support services

Awareness

We raise awareness for diagnosis and promote mutual exchange

Learn more about awareness initiatives

Research

We support and promote research in the field of amyloidosis

Learn more about our research activities

Donate

Your donation helps support patients and advance research

Learn more about donation opportunities
Stronger Together

Become Part of Our Community

As a member of Amyloidosis Switzerland, you not only support our important work but also benefit from a strong network and mutual exchange.

  • Connect with other patients and family members
  • Receive regular updates and newsletters
  • Benefit from peer exchange and mutual support
  • Strengthen the voice of those affected together

Together We Are Stronger

Every member helps raise awareness about amyloidosis and advance research.

Your membership makes a difference

Our Partners

  • Pfizer logo
  • MediService by Redcare logo
  • Alnylam logo
  • AstraZeneca logo
  • Bayer logo
  • Johnson & Johnson logo
  • Medtronic logo
  • Abbott logo
  • Alexion logo

Amyloidosis Switzerland Association

charitable organization

CH-6130 Willisau

info@amyloidose-schweiz.ch

Subscribe to our Newsletter

The latest news, articles, and resources, regularly in your inbox.

© 2024 - 2026 Amyloidosis Switzerland Association. All rights reserved

Website by Grifo Development